Mark Henderson

2.7k total citations · 2 hit papers
41 papers, 2.0k citations indexed

About

Mark Henderson is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Henderson has authored 41 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 18 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Henderson's work include Coronary Interventions and Diagnostics (11 papers), Acute Myocardial Infarction Research (10 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Mark Henderson is often cited by papers focused on Coronary Interventions and Diagnostics (11 papers), Acute Myocardial Infarction Research (10 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Mark Henderson collaborates with scholars based in Canada, United States and United Kingdom. Mark Henderson's co-authors include E.Douglas Wigle, Harry Rakowski, Zion Sasson, William G. Williams, John Fulop, Terrence D. Ruddy, Leonard Schwartz, Harold E. Aldridge, Martial G. Bourassa and Raoul Bonan and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Mark Henderson

41 papers receiving 1.9k citations

Hit Papers

Hypertrophic cardiomyopathy. The importance of the site a... 1985 2026 1998 2012 1985 1988 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review
    1985 579 citations E.Douglas Wigle, Zion Sasson et al. profile →
  2. Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary Angioplasty
    1988 516 citations Leonard Schwartz, Martial G. Bourassa et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Henderson Canada 15 1.5k 923 389 232 229 41 2.0k
Masami Nishino Japan 24 1.1k 0.7× 613 0.7× 306 0.8× 382 1.6× 193 0.8× 198 1.6k
Volker Schächinger Germany 20 1.3k 0.8× 669 0.7× 512 1.3× 345 1.5× 427 1.9× 64 1.7k
James L. Orford United States 15 872 0.6× 695 0.8× 217 0.6× 272 1.2× 123 0.5× 39 1.3k
Kohei Wakabayashi United States 19 796 0.5× 426 0.5× 185 0.5× 311 1.3× 280 1.2× 66 1.1k
Si Wan Choi South Korea 18 1.0k 0.7× 699 0.8× 252 0.6× 234 1.0× 84 0.4× 92 1.4k
Berrin Umman Türkiye 19 798 0.5× 373 0.4× 346 0.9× 104 0.4× 69 0.3× 71 1.1k
Ümit Güray Türkiye 19 674 0.4× 263 0.3× 136 0.3× 134 0.6× 210 0.9× 95 1.0k
Wolfram Terres Germany 17 518 0.3× 438 0.5× 176 0.5× 131 0.6× 63 0.3× 58 960
P Bareiss France 16 907 0.6× 311 0.3× 199 0.5× 257 1.1× 56 0.2× 43 1.2k
Hans Mickley Denmark 17 769 0.5× 229 0.2× 296 0.8× 123 0.5× 175 0.8× 45 1.0k

Countries citing papers authored by Mark Henderson

Since Specialization
Citations

This map shows the geographic impact of Mark Henderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Henderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Henderson more than expected).

Fields of papers citing papers by Mark Henderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Henderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Henderson. The network helps show where Mark Henderson may publish in the future.

Co-authorship network of co-authors of Mark Henderson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Henderson. A scholar is included among the top collaborators of Mark Henderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Henderson. Mark Henderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Shurrab, Mohammed, et al.. (2021). The Gap in Prescribing Stroke Prevention Therapies in Postoperative Atrial Fibrillation After Isolated Coronary Artery Bypass Grafting Surgery. The Heart Surgery Forum. 24(3). E580–E586. 1 indexed citations
3.
Shurrab, Mohammed, Dennis T. Ko, Janet E. McElhaney, et al.. (2019). Identifying Factors That Predict the Prescription of Non–vitamin K Antagonist Oral Anticoagulants in Older Individuals With Atrial Fibrillation. Journal of the American Medical Directors Association. 20(8). 984–987. 6 indexed citations
4.
Russo, Juan, Shaun G. Goodman, Akshay Bagai, et al.. (2016). Duration of dual antiplatelet therapy and associated outcomes following percutaneous coronary intervention for acute myocardial infarction: contemporary practice insights from the Canadian Observational Antiplatelet Study. European Heart Journal - Quality of Care and Clinical Outcomes. 3(4). qcw051–qcw051. 7 indexed citations
5.
6.
Chan, Albert W. & Mark Henderson. (2006). Immediate catheter‐directed reperfusion for acute stroke occurring during diagnostic cardiac catheterization. Catheterization and Cardiovascular Interventions. 67(2). 314–318. 7 indexed citations
7.
Rankin, James M., John J. Spinelli, Ronald G. Carere, et al.. (1999). Improved Clinical Outcome after Widespread Use of Coronary-Artery Stenting in Canada. New England Journal of Medicine. 341(26). 1957–1965. 91 indexed citations
8.
Rankin, Jamie, et al.. (1998). Increasing use of coronary stents is associated with a reduced requirement for repeat intervention in a large unselected population of patients referred for PTCA. Journal of the American College of Cardiology. 31. 216–216. 1 indexed citations
9.
Myers, Michael J. & Mark Henderson. (1996). Assessment of two devices for measuring tympanic membrane temperature in swine, dairy cattle, and dairy calves. Journal of the American Veterinary Medical Association. 208(10). 1700–1701. 7 indexed citations
10.
Myers, Michael J., et al.. (1995). Effect of Recombinant Growth Hormone and Chromium Picolinate on Cytokine Production and Growth Performance in Swine. Pathobiology. 63(5). 283–287. 17 indexed citations
11.
Kells, Catherine, et al.. (1990). Left main coronary artery disease progression after percutaneous transluminal coronary angioplasty. The American Journal of Cardiology. 65(7). 513–514. 12 indexed citations
12.
Macdonald, R. Glen, Mark Henderson, John W. Hirshfeld, et al.. (1990). Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty — A report from the M-HEART Groupt. The American Journal of Cardiology. 66(12). 926–931. 56 indexed citations
13.
Sasson, Zion, Tim Prieur, Yoanna Skrobik, et al.. (1989). Aortic regurgitation: A common complication after surgery for hypertrophic obstructive cardiomyopathy. Journal of the American College of Cardiology. 13(1). 63–67. 27 indexed citations
14.
Sasson, Zion, Mark Henderson, Susan Wilansky, Harry Rakowski, & E.Douglas Wigle. (1989). Causal relation between the pressure gradient and left ventricular ejection time in hypertrophic cardiomyopathy. Journal of the American College of Cardiology. 13(6). 1275–1279. 19 indexed citations
15.
Schwartz, Leonard, Martial G. Bourassa, Jacques Lespérance, et al.. (1988). Aspirin and Dipyridamole in the Prevention of Re-Stenosis after Percutaneous Transluminal Coronary Angioplasty. New England Journal of Medicine. 318(26). 1714–1719. 516 indexed citations breakdown →
16.
Pollick, Charles, Brian P. Kimball, Mark Henderson, & E.Douglas Wigle. (1988). Disopyramide in hypertrophic cardiomyopathy I. Hemodynamic assessment after intravenous administration. The American Journal of Cardiology. 62(17). 1248–1251. 75 indexed citations
17.
Schwartz, Leonard, et al.. (1987). Complications associated with the guide wire in percutaneous transluminal coronary angioplasty. Journal of the American College of Cardiology. 10(1). 218–221. 24 indexed citations
18.
Marquis, Jean-François, et al.. (1984). Acute coronary artery occlusion during percutaneous transluminal coronary angioplasty treated by redilation of the occluded segment. Journal of the American College of Cardiology. 4(6). 1268–1271. 60 indexed citations
19.
Henderson, Mark, et al.. (1977). Ventricular arrhythmias caused by prenylamine.. BMJ. 2(6087). 608–609. 34 indexed citations
20.
Sinclair, Ian, Mark Henderson, & Dinee C. Simpson. (1961). FLUON ARTERIOVENOUS SHUNT FOR REPEATED HÆMODIALYSIS. The Lancet. 278(7199). 410–410. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masami Nishino Breakdown of academic impact, for papers by Volker Schächinger Breakdown of academic impact, for papers by James L. Orford Breakdown of academic impact, for papers by Kohei Wakabayashi Breakdown of academic impact, for papers by Si Wan Choi Breakdown of academic impact, for papers by Berrin Umman Breakdown of academic impact, for papers by Ümit Güray Breakdown of academic impact, for papers by Wolfram Terres Breakdown of academic impact, for papers by P Bareiss Breakdown of academic impact, for papers by Hans Mickley
Rankless by CCL
2026